Literature DB >> 22932112

[Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].

Kuang-rong Wei1, Wan-qing Chen, Si-wei Zhang, Rong-shou Zheng, Ya-na Wang, Zhi-heng Liang.   

Abstract

OBJECTIVE: To analyze corpus uteri epidemiology in selected cancer registering areas of China during 2003 - 2007, and to provide scientific information for its prevention and control in China.
METHODS: The incident and mortality data of corpus uteri cancer in 32 cancer registering areas of China with better quality during 2003 - 2007, which were selected according to the criteria of and provided by National Center for Cancer Registration, were analyzed.
RESULTS: There were 8850 new cases and 1559 death cases of corpus uteri cancer, which accounted for 2.96% (8 850/299 306) of all female new cancer cases and 0.94% (1 559/166 305) of all female cancer death cases, respectively. Corpus uteri cancer was the 9th most common cancer for all new female cancer cases which world age adjusted incidence rates was 5.04/10⁵, and 19th most common cancer for all female cancer death cases which world age adjusted mortality rate was 0.83/10⁵ in 32 selected cancer registering areas of China during 2003 - 2007. Zhongshan city, Guangzhou city in Guangdong province and Beijing were the areas with the highest incidence rates in which were 14.51/10⁵, 8.51/10⁵ and 6.69/10⁵, respectively. Zhongshan city in Guangdong province, Dafeng city in Jiangsu province and Feicheng city in Shandong province were the areas with the highest mortality rates, in which were 4.03/10⁵, 3.19/10⁵ and 1.65/10⁵ respectively during 2003 - 2007. There were increasing trends for its incidence rates in above 32 areas during 2003 - 2007, its world age adjusted incidence rates increased from 3.94/10⁵ in 2003 to 5.56/10⁵ in 2007 (P = 0.026), while its urban world age adjusted incidence rates increased from 4.57/10⁵ in 2003 to 6.18/10⁵ in 2007 (P = 0.038), and rural rates increased from 1.74/10⁵ in 2003 to 3.01/10⁵ in 2007 (P = 0.013), and the results showed that urban areas obviously higher than rural areas (P < 0.01). Although there was a slow increasing trend for its world age adjusted mortality rates in above 32 areas during 2003 - 2007 which increased from 0.64/10⁵ in 2003 to 0.87/10⁵ in 2007 (P = 0.214), and from 0.66/10⁵ in 2003 to 0.88/10⁵ in 2007 in urban areas (P = 0.340), and from 0.57/10⁵ in 2003 to 0.83/10⁵ in 2007 in rural areas (P = 0.070), while increasing trends without statistical significance.But mortality rates in urban areas were obviously higher than those of rural areas (P < 0.01).
CONCLUSIONS: Although the world standardized incidence and mortality rates of corpus uteri cancer were at low level worldwide, there were increasing trends for its incidence rates during 2003 - 2007 in the 32 selected cancer registering areas of China. Moreover, its incidence and mortality rates were at high level worldwide in some areas such as Zhongshan city of Guangdong province and Dafeng city of Jiangsu province during the period, in which suggested that its prevention and control should be enhanced.

Entities:  

Mesh:

Year:  2012        PMID: 22932112

Source DB:  PubMed          Journal:  Zhonghua Fu Chan Ke Za Zhi        ISSN: 0529-567X


  9 in total

1.  Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism.

Authors:  Mingzhu Bai; Linlin Yang; Hong Liao; Xiaoyan Liang; Bingying Xie; Ji Xiong; Xiang Tao; Xiong Chen; Yali Cheng; Xiaojun Chen; Youji Feng; Zhenbo Zhang; Wenxin Zheng
Journal:  Oncogene       Date:  2018-06-19       Impact factor: 9.867

2.  Impact of known risk factors on endometrial cancer burden in Chinese women.

Authors:  Jing Gao; Gong Yang; Wanqing Wen; Qiu-Yin Cai; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Eur J Cancer Prev       Date:  2016-07       Impact factor: 2.497

3.  TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention.

Authors:  Xiao Yang; Gan Tao Chen; Yan Qing Wang; Shu Xian; Li Zhang; Shao Ming Zhu; Feng Pan; Yan Xiang Cheng
Journal:  Mol Med Rep       Date:  2017-11-20       Impact factor: 2.952

4.  Significance of calreticulin as a prognostic factor in endometrial cancer.

Authors:  Qin Xu; Chuanben Chen; Guilin Chen; Wei Chen; Dongmei Zhou; Yunqing Xie
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

5.  Clinicopathologic features of endometrial cancer in Chinese patients younger than 50 years with a family history of cancer.

Authors:  Yuan He; Xiang Tao; Feifei Huang; Nan Jia; Yan Du; Jinming Yu; Weiwei Feng
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

6.  Trends in incidence of uterine cancer in Songkhla, Southern Thailand.

Authors:  Nungrutai Saeaib; Hutcha Sriplung; Aroontorn Pichatechaiyoot; Surichai Bilheem
Journal:  J Gynecol Oncol       Date:  2018-11-22       Impact factor: 4.401

7.  Incidence and mortality of corpus uteri cancer in China, 2008-2012.

Authors:  Yunfeng Xi; Wenrui Wang; Wenjie Chen; Ke Han; Liying Qiao; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2019-06       Impact factor: 5.087

8.  Preoperative platelet morphology parameters as prognostic predictors for endometrial malignant carcinoma stage and progesterone receptor.

Authors:  Jianrong Song; Xiaohong Lai; Yulong Zhang; Xiangqin Zheng; Jiangcheng Su
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

9.  Spatiotemporal trends in burden of uterine cancer and its attribution to body mass index in 204 countries and territories from 1990 to 2019.

Authors:  Songbo Li; Hui Chen; Tongchao Zhang; Rongrong Li; Xiaolin Yin; Jinyu Man; Qiufeng He; Xiaorong Yang; Ming Lu
Journal:  Cancer Med       Date:  2022-02-13       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.